“The Danish National Health Commission has stated that the benefits of using Johnson & Johnson’s Covid-19 vaccine cause vaccine-induced thrombocytopenia (VITT), a possible side effect in vaccinated individuals. We conclude that the risk is not exceeded. The Danish National Health Commission will continue the Danish mass vaccination program for Covid-19 without Johnson & Johnson’s Covid-19 vaccine, “said Danish Health. After reading the Commission’s statement, Euronews reported.
Previously, Denmark also discontinued the AstraZeneca vaccine because of concerns about “rare” but “serious” side effects. The decision has never been so easy.
“Given the current situation in Denmark, what we are currently losing to prevent serious illness from Covid-19 outweighs the risk of causing side effects that can occur in the form of severe blood clots in vaccinated people. I can’t, “the statement said. Said.
Health officials added that the decision “has a significant impact” on the deployment of vaccinations for people between the ages of 20 and 39. This can be up to 4 weeks late.
“The rest of the target group will have a delay of about a week due to the large availability of other vaccines,” reads the statement.
“Of course, this decision affects people who are postponing vaccination. For example, many people have to wait for a corona passport that they are looking forward to getting. Age is the main risk factor. Covid It is a serious illness due to -19 and these are young citizens who are not at risk of becoming seriously ill. “
As of May 1, more than 1.3 million of the country’s 5.8 million population had been vaccinated at least once, according to Our World in Data.
The Johnson & Johnson vaccine, known as Janssen, is the fourth to be approved for use throughout the European Union by the European Medicines Agency (EMA) in March after Pfizer / BioNTech, AstraZeneca / Oxford University and Moderna reported to Euronews. It became a jab of.
However, a US pharmaceutical company has postponed delivery to a block of 27 members after reports of serious blood clots in the United States, where more than 6.8 million people received at least one injection.
The EMA began a review last month, but Euronews reported that “the benefits of vaccines in preventing Covid-19 outweigh the risks of side effects.”